Navellier & Associates’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,565
| Closed | -$489K | – | 336 |
|
|
2024
Q2 | $489K | Buy |
+3,565
| New | +$489K | 0.06% | 244 |
|
|
2021
Q4 | – | Sell |
-2,316
| Closed | -$374K | – | 334 |
|
|
2021
Q3 | $374K | Buy |
+2,316
| New | +$374K | 0.06% | 233 |
|
|
2021
Q2 | – | Sell |
-3,303
| Closed | -$497K | – | 323 |
|
|
2021
Q1 | $497K | Buy |
+3,303
| New | +$497K | 0.09% | 179 |
|
|
2020
Q1 | – | Sell |
-17,677
| Closed | -$2.13M | – | 262 |
|
|
2019
Q4 | $2.13M | Buy |
+17,677
| New | +$2.13M | 0.34% | 84 |
|
|
2018
Q4 | – | Sell |
-62,187
| Closed | -$7.58M | – | 265 |
|
|
2018
Q3 | $7.58M | Buy |
+62,187
| New | +$7.58M | 0.98% | 26 |
|
|
2018
Q1 | – | Sell |
-6,750
| Closed | -$721K | – | 318 |
|
|
2017
Q4 | $721K | Buy |
+6,750
| New | +$721K | 0.13% | 157 |
|
|
2017
Q1 | – | Sell |
-40,095
| Closed | -$3.55M | – | 297 |
|
|
2016
Q4 | $3.55M | Buy |
40,095
+6,366
| +19% | +$563K | 0.59% | 73 |
|
|
2016
Q3 | $3.25M | Buy |
+33,729
| New | +$3.25M | 0.47% | 72 |
|
|
2015
Q3 | – | Sell |
-12,465
| Closed | -$1.53M | – | 345 |
|
|
2015
Q2 | $1.53M | Buy |
12,465
+3,051
| +32% | +$375K | 0.13% | 85 |
|
|
2015
Q1 | $1.08M | Buy |
+9,414
| New | +$1.08M | 0.1% | 105 |
|